Summit X, LLC Mesoblast LTD Transaction History

Summit X, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$1.0 - $1.39 $3,001 - $4,171	3,001 Added 10.71%	31,011 $34,000
Q3 2023 Nov 03, 2023	BUY	$1.22 - $4.83 $3,416 - $13,524	2,800 Added 11.11%	28,010 $34,000
Q2 2023 Aug 09, 2023	BUY	$2.95 - $4.44 $20,647 - $31,075	6,999 Added 38.43%	25,210 $98,000
Q1 2023 May 10, 2023	BUY	$2.94 - $4.18 $1,181 - $1,680	402 Added 2.26%	18,211 $59,000
Q4 2022 Feb 02, 2023	BUY	$2.73 - $3.7 $7,264 - $9,845	2,661 Added 17.57%	17,809 $51,000
Q3 2022 Nov 01, 2022	SELL	$0.48 - $3.48 $1,277 - $9,260	-2,661 Reduced 14.94%	15,148 $42,000
Q2 2022 Aug 12, 2022	BUY	$2.22 - $4.54 $6,660 - $13,620	3,000 Added 20.26%	17,809 $39,000
Q1 2022 May 05, 2022	BUY	$3.58 - $4.98 $53,016 - $73,748	14,809 New	14,809 $60,000
Q4 2020 Jan 29, 2021	SELL	$8.21 - $18.59 $148,921 - $337,204	-18,139 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$11.33 - $19.81 $205,514 - $359,333	18,139 New	18,139 $539,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.57B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit X, LLC with notifications on news.